vpv7.bsky.social
@vpv7.bsky.social
Efficacy of praziquantel for treatment of Plasmodium falciparum infection in asymptomatic Gabonese adults: A double-blind placebo-controlled randomized phase IIb clinical trial

✅ Just Accepted
🔗 https://bit.ly/47Y2ic9
November 10, 2025 at 5:22 PM
Emergence of acquired HIV drug resistance among individuals receiving dolutegravir-based antiretroviral therapy in Uganda: A national laboratory-based survey 2023

✅ Just Accepted
🔗 https://bit.ly/482RwkM
November 10, 2025 at 5:22 PM
The win ratio should be complemented by other win statistics to provide a comprehensive picture of relative and absolute treatment effects: the case study of the REPRIEVE trial

✅ Just Accepted
🔗 https://bit.ly/4oqSQE6
November 4, 2025 at 5:50 PM
Sustained HIV suppression with co-formulated tenofovir disoproxil fumarate/lamivudine/dolutegravir in a person with transmitted dolutegravir resistance and pre-treatment resistance to lamivudine: a case report from HPTN 083

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4oxIGRA
October 28, 2025 at 1:36 AM
Longitudinal patient-reported outcome trajectories in Long COVID: Findings from the STOP-PASC Clinical Trial

✅ Just Accepted
#IDSky
🔗 https://bit.ly/47occn5
October 19, 2025 at 10:57 PM
COVID-19 Vaccine Effectiveness in Patients with Hematologic Malignancies: a Nationwide Cohort Study

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nZcC9q
October 19, 2025 at 10:57 PM
Modeling the potential impact of mentor mother programs on vertical transmission of HIV in Kenya

✅ Just Accepted
#IDSky
🔗 https://bit.ly/46XHP5A
October 13, 2025 at 3:02 PM
Fever in sepsis revisited: Is a little heat what we need?

✅ Just Accepted
#IDTwitter

🔗 https://bit.ly/3IBg4ry
October 13, 2025 at 3:02 PM
Severity of Clinical Presentation and Outcomes in Hospitalized Adult Patients with Influenza by Type and Subtype, United States?2017?2020

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48FSdkL
October 5, 2025 at 9:16 PM
Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4o1oLdK
October 5, 2025 at 9:16 PM
Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4pxWnBd
September 30, 2025 at 2:10 AM
The major outer membrane protein P5 binds vitronectin to mediate serum resistance in non-typable Haemophilus influenzae

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4nRAGL1
September 30, 2025 at 2:10 AM
Neurological sequelae after encephalitis associated with dengue virus in children

✅ Just Accepted
#IDSky
🔗 https://bit.ly/46edGji
September 21, 2025 at 7:52 PM
Updating the epidemiology of blastomycosis and histoplasmosis in the United States, using national electronic health record data, 2013 - 2023

✅ Just Accepted
#IDSky
🔗 https://bit.ly/48czqNM
September 15, 2025 at 2:03 AM
Febrile temperature augments ring-stage Plasmodium falciparum adhesion to brain endothelial cells

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4glzg8Z
September 15, 2025 at 2:03 AM
Febrile temperature augments ring-stage Plasmodium falciparum adhesion to brain endothelial cells

✅ Just Accepted
#IDSky
🔗 https://bit.ly/4glzg8Z
September 15, 2025 at 2:01 AM
Re-emergence of diphtheria in Guinea: An outbreak analysis of vaccination and disease control perspectives.

✅ Just Accepted
#IDSky

https://bit.ly/3VEFGX2
September 8, 2025 at 5:47 PM
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study Results

✅ Just Accepted
#IDSky
September 8, 2025 at 5:47 PM
The blood-sucking insects are infecting humans and animals in Texas.
September 8, 2025 at 5:47 PM
Association between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes among Hospitalized Adult Patients with Candidemia Who Received Empiric Treatment with an Echinocandin Across United States Hospitals

✅ Just Accepted
#IDSky
September 8, 2025 at 5:46 PM